COMP <GO>
SNDR vs TMO // RETURN ON INVESTED CAPITAL (ROIC)
Schneider National Inc. (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: SNDR 5
— TMO 8
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: TMO
LAST: $29.23 (-0.75%) • MKT CAP: $5.16B
roic
4.20%
LAST: $697.00 (-1.72%) • MKT CAP: $262.22B
roic
9.30%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SNDR VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | SNDR | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | 41.00% | 0.00 | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | 4.20% | 9.30% | -5.10 | TMO | /roic <GO> |
| EV/EBITDA & P/E Valuation | 11.4x | 30.4x | -19.00 | SNDR | /valuation <GO> |
| Free Cash Flow Yield | 5.53% | 2.40% | +3.13 | SNDR | /fcf-yield <GO> |
| Operating Margin | 3.00% | 17.40% | -14.40 | TMO | /operating-margins <GO> |
| Net Profit Margin | 1.80% | 15.10% | -13.30 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | 7.30% | 3.90% | +3.40 | SNDR | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.30% | 0.24% | +1.06 | SNDR | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.59 | 4.50 | -0.91 | TMO | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 8/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.10% | 6.70% | +0.40 | TMO | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 32.4 | 59.1 | -26.72 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.07 | 0.94 | +0.13 | SNDR | /macro-sensitivity <GO> |
| Forward P/E Multiple | 46.3x | 36.3x | +10.00 | TMO | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $5.16B | $262.22B | -$257.05B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | SNDR REV | TMO REV | SNDR GROSS % | TMO GROSS % | SNDR FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $5.67B | $44.56B | 44.0% | 44.0% | $285.4M | $6.29B |
| FY 2024 | $5.29B | $42.88B | 44.0% | 44.0% | $272.1M | $7.27B |
| FY 2023 | $5.50B | $42.86B | 44.0% | 44.0% | $432.5M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SNDR // BETA 1.07
TMO // BETA 0.94